Amarin Corp Plc (AMRN)

[north40000]

Does anyone think we will obtain analyst Price Target increases as a result of the earnings conference call?

To JRoon: I don't think PFE is out of the running on a M/A activity that might include AMRN. PFE CEO was interviewed on CNBC-TV this morning. I thought I heard him say that PFE is always in the hunt for further bolt-on acquisitions, and that their planned M/A activity for 2023 is 80-90% complete. SGEN is expected to finalize in 2023 or 2024, which will be big for us. PRVB did finalize in the past few days. PFE has done nothing so far in the CVD sector space that I am aware of besides partner with HLS in Canada to sell Vascepa to general practitioners. The Mitigate and AD clinical trials that are ongoing may greatly excite interest in Amarin's Vascepa should results prove favorable.